New Triple-Action antibody takes on Hard-to-Treat lymphoma

NCT ID NCT07308132

First seen Jan 05, 2026 · Last updated May 01, 2026 · Updated 21 times

Summary

This early-phase study tests an experimental drug called JNJ-95566692, alone or with another drug, in people with B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior treatments. The main goals are to find a safe dose and check for side effects. About 130 adults will take part, and the study is currently recruiting.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYMPHOMA, NON-HODGKIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ankara Universitesi Hastaneleri Tibbi Farmakoloji Anabilim Dali Faz 1 Klinik Arastirma Merkezi

    RECRUITING

    Ankara, 06620, Turkey (Türkiye)

  • Centre Hospitalier Universitaire de Liege Domaine Universitaire du Sart Tilman

    RECRUITING

    Liège, 4000, Belgium

  • Koc Universitesi Hastanesi Faz 1 Klinik Arastirma Merkezi

    RECRUITING

    Istanbul, 34010, Turkey (Türkiye)

  • Macquarie University Hospital

    RECRUITING

    North Ryde, 2109, Australia

  • Peter MacCallum Cancer Centre

    RECRUITING

    Melbourne, 3000, Australia

  • SBU Ankara Dr. Abdurrahman Yurtaslan Onkoloji Egitim ve Arastirma Hastanesi Faz 1 Merkezi

    RECRUITING

    Ankara, 06200, Turkey (Türkiye)

  • Scientia Clinical Research

    RECRUITING

    Randwick, 2031, Australia

  • UZ Antwerpen

    RECRUITING

    Edegem, 2650, Belgium

Conditions

Explore the condition pages connected to this study.